1. Home
  2. XENE vs MGRC Comparison

XENE vs MGRC Comparison

Compare XENE & MGRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • MGRC
  • Stock Information
  • Founded
  • XENE 1996
  • MGRC 1979
  • Country
  • XENE Canada
  • MGRC United States
  • Employees
  • XENE N/A
  • MGRC N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • MGRC Diversified Commercial Services
  • Sector
  • XENE Health Care
  • MGRC Consumer Discretionary
  • Exchange
  • XENE Nasdaq
  • MGRC Nasdaq
  • Market Cap
  • XENE 3.3B
  • MGRC 3.0B
  • IPO Year
  • XENE 2014
  • MGRC N/A
  • Fundamental
  • Price
  • XENE $41.08
  • MGRC $118.52
  • Analyst Decision
  • XENE Strong Buy
  • MGRC Buy
  • Analyst Count
  • XENE 9
  • MGRC 2
  • Target Price
  • XENE $56.67
  • MGRC $145.50
  • AVG Volume (30 Days)
  • XENE 361.3K
  • MGRC 133.7K
  • Earning Date
  • XENE 11-12-2024
  • MGRC 10-24-2024
  • Dividend Yield
  • XENE N/A
  • MGRC 1.61%
  • EPS Growth
  • XENE N/A
  • MGRC 23.19
  • EPS
  • XENE N/A
  • MGRC 9.15
  • Revenue
  • XENE N/A
  • MGRC $888,783,000.00
  • Revenue This Year
  • XENE N/A
  • MGRC $12.08
  • Revenue Next Year
  • XENE $1,599.99
  • MGRC $0.48
  • P/E Ratio
  • XENE N/A
  • MGRC $12.97
  • Revenue Growth
  • XENE N/A
  • MGRC 12.06
  • 52 Week Low
  • XENE $35.53
  • MGRC $95.50
  • 52 Week High
  • XENE $50.99
  • MGRC $130.86
  • Technical
  • Relative Strength Index (RSI)
  • XENE 48.67
  • MGRC 47.92
  • Support Level
  • XENE $38.95
  • MGRC $116.19
  • Resistance Level
  • XENE $43.20
  • MGRC $121.21
  • Average True Range (ATR)
  • XENE 1.51
  • MGRC 2.34
  • MACD
  • XENE -0.11
  • MGRC -0.69
  • Stochastic Oscillator
  • XENE 51.27
  • MGRC 34.01

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

About MGRC McGrath RentCorp

McGrath RentCorp is a rental company. It is comprised of four reportable business segments: Modular building and portable storage segment (Mobile Modular), Electronic test equipment segment (TRS-RenTelco), Containment solutions for the storage of hazardous and non-hazardous liquids and solids segment (Adler Tanks) and Classroom manufacturing division selling modular classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.

Share on Social Networks: